Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
107.32 USD
0.43%
Market Closed
Updated:
Apr 26, 2024
Abbott Laboratories
Interest Income Expense
|
Abbott Laboratories
Interest Income Expense Peer Comparison
Comparables:
BDX
BSX
EW
SYK
ISRG
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbott Laboratories
NYSE:ABT
|
Interest Income Expense
-$296m
|
CAGR 3-Years
16%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-13%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Interest Income Expense
-$384m
|
CAGR 3-Years
9%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-16%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Interest Income Expense
-$537m
|
CAGR 3-Years
-325%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
-5%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Interest Income Expense
$59.4m
|
CAGR 3-Years
43%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Interest Income Expense
-$281m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Interest Income Expense
$227m
|
CAGR 3-Years
11%
|
CAGR 5-Years
19%
|
CAGR 10-Years
29%
|
See Also
What is Abbott Laboratories's Interest Income Expense?
Interest Income Expense
-296m
USD
-296m
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Interest Income Expense amounts to -296m USD.
What is Abbott Laboratories's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-13%
-13%
Over the last year, the Interest Income Expense growth was 8%. The average annual Interest Income Expense growth rates for Abbott Laboratories have been 16% over the past three years , 16% over the past five years , and -13% over the past ten years .
You don't have any saved screeners yet
